Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10915946 | Nuclear Medicine and Biology | 2015 | 6 Pages |
Abstract
The MPO inhibitor AZD3241 was successfully labeled with carbon-11 in a challenging 4-step procedure in good radiochemical yield allowing PET microdosing studies in cynomolgus monkey. [11C]AZD3241 rapidly entered brain and confirmed adequate brain exposure to support translation of AZD3241 to phase 2a studies in patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Peter Johnström, Linda Bergman, Katarina Varnäs, Jonas Malmquist, Christer Halldin, Lars Farde,